Psilocybin for Depression: From Credibility to Feasibility, What’s Missing?
Psilocybin has been suggested as a promising transdiagnostic treatment strategy for a wide range of psychiatric disorders. Recent findings showed that psychedelic-assisted/”psycholitic” psychotherapy should provide significant and sustained alleviation of depressive symptoms. However, to date, there...
| 主要な著者: | , , , , , |
|---|---|
| フォーマット: | 論文 |
| 言語: | English |
| 出版事項: |
MDPI AG
2022-12-01
|
| シリーズ: | Pharmaceuticals |
| 主題: | |
| オンライン･アクセス: | https://www.mdpi.com/1424-8247/16/1/68 |